{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:50:53Z","timestamp":1740124253133,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-023-03793-w","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T09:02:07Z","timestamp":1695459727000},"page":"547-556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Causal relationship between prostate cancer and 12 types of cancers: multivariable and bidirectional Mendelian randomization analyses"],"prefix":"10.1007","volume":"56","author":[{"given":"Xiangpeng","family":"Zhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Situ","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6686-7561","authenticated-orcid":false,"given":"Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,23]]},"reference":[{"issue":"1","key":"3793_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72(1):7\u201333","journal-title":"CA Cancer J Clin"},{"issue":"1\u20132","key":"3793_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000381716","volume":"102","author":"AK Clift","year":"2015","unstructured":"Clift AK, Drymousis P, Al-Nahhas A, Wasan H, Martin J, Holm S et al (2015) Incidence of second primary malignancies in patients with neuroendocrine tumours. Neuroendocrinology 102(1\u20132):26\u201332","journal-title":"Neuroendocrinology"},{"issue":"1","key":"3793_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ygyno.2014.10.029","volume":"136","author":"E Molina-Montes","year":"2015","unstructured":"Molina-Montes E, Requena M, S\u00e1nchez-Cantalejo E, Fern\u00e1ndez MF, Arroyo-Morales M, Esp\u00edn J et al (2015) Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. Gynecol Oncol 136(1):158\u2013171","journal-title":"Gynecol Oncol"},{"issue":"21","key":"3793_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14215204","volume":"14","author":"G Collatuzzo","year":"2022","unstructured":"Collatuzzo G, Ferrante M, Ippolito A, Di Prima A, Colarossi C, Scarpulla S et al (2022) Second primary cancers following colorectal cancer in Sicily, Italy. Cancers 14(21):1","journal-title":"Cancers"},{"issue":"24","key":"3793_CR5","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2020.23130","volume":"324","author":"H Sung","year":"2020","unstructured":"Sung H, Hyun N, Leach CR, Yabroff KR, Jemal A (2020) Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in the United States. JAMA 324(24):2521\u20132535","journal-title":"JAMA"},{"issue":"6","key":"3793_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/j.semnuclmed.2016.07.002","volume":"46","author":"M Nguyen-Nielsen","year":"2016","unstructured":"Nguyen-Nielsen M, Borre M (2016) Diagnostic and therapeutic strategies for prostate cancer. Semin Nucl Med 46(6):484\u2013490","journal-title":"Semin Nucl Med"},{"issue":"11","key":"3793_CR7","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1002\/cam4.1764","volume":"7","author":"S Chattopadhyay","year":"2018","unstructured":"Chattopadhyay S, Zheng G, Hemminki O, F\u00f6rsti A, Sundquist K, Hemminki K (2018) Prostate cancer survivors: risk and mortality in second primary cancers. Cancer Med 7(11):5752\u20135759","journal-title":"Cancer Med"},{"issue":"6","key":"3793_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.bjc.6605263","volume":"101","author":"H Zhang","year":"2009","unstructured":"Zhang H, Bermejo JL, Sundquist J, Hemminki K (2009) Prostate cancer as a first and second cancer: effect of family history. Br J Cancer 101(6):935\u2013939","journal-title":"Br J Cancer"},{"issue":"1","key":"3793_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1166-7087(07)92222-8","volume":"17","author":"Y Neuzillet","year":"2007","unstructured":"Neuzillet Y, Lechevallier E, Coulange C (2007) Renal cancer and second cancer: critical review of the literature. Progres en urologie: journal de l\u2019Association francaise d\u2019urologie et de la Societe francaise d\u2019urologie 17(1):35\u201340","journal-title":"Progres en urologie: journal de l'Association francaise d'urologie et de la Societe francaise d'urologie"},{"issue":"7","key":"3793_CR10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658\u2013665","journal-title":"Genet Epidemiol"},{"issue":"7","key":"3793_CR11","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ et al (2018) Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet 50(7):928\u2013936","journal-title":"Nat Genet"},{"key":"3793_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7:1","journal-title":"Elife"},{"issue":"R2","key":"3793_CR13","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","volume":"27","author":"G Hemani","year":"2018","unstructured":"Hemani G, Bowden J, Davey SG (2018) Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet 27(R2):R195-r208","journal-title":"Hum Mol Genet"},{"issue":"4","key":"3793_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304\u2013314","journal-title":"Genet Epidemiol"},{"issue":"2","key":"3793_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512\u2013525","journal-title":"Int J Epidemiol"},{"issue":"3","key":"3793_CR16","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1245\/s10434-014-4066-y","volume":"22","author":"JJ Tomaszewski","year":"2015","unstructured":"Tomaszewski JJ, Uzzo RG, Egleston B, Corcoran AT, Mehrazin R, Geynisman DM et al (2015) Coupling of prostate and thyroid cancer diagnoses in the United States. Ann Surg Oncol 22(3):1043\u20131049","journal-title":"Ann Surg Oncol"},{"issue":"17","key":"3793_CR17","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/cncr.28769","volume":"120","author":"EJ Davis","year":"2014","unstructured":"Davis EJ, Beebe-Dimmer JL, Yee CL, Cooney KA (2014) Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study. Cancer 120(17):2735\u20132741","journal-title":"Cancer"},{"issue":"4","key":"3793_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/jamaoncol.2018.5321","volume":"5","author":"AS Ho","year":"2019","unstructured":"Ho AS, Daskivich TJ, Sacks WL, Zumsteg ZS (2019) Parallels between low-risk prostate cancer and thyroid cancer: a review. JAMA Oncol 5(4):556\u2013564","journal-title":"JAMA Oncol"},{"issue":"12","key":"3793_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1089\/thy.2007.0171","volume":"17","author":"S Subramanian","year":"2007","unstructured":"Subramanian S, Goldstein DP, Parlea L, Thabane L, Ezzat S, Ibrahim-Zada I et al (2007) Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid Off J Am Thyroid Assoc 17(12):1277\u20131288","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"11","key":"3793_CR20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10552-020-01336-7","volume":"31","author":"DR Withrow","year":"2020","unstructured":"Withrow DR, Schonfeld SJ, Curtis RE, Morton LM, Cook MB, Butler EN et al (2020) Racial and ethnic differences in risk of second primary cancers among prostate cancer survivors. Cancer Causes Control CCC 31(11):1011\u20131019","journal-title":"Cancer Causes Control CCC"},{"issue":"2","key":"3793_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/cncr.29025","volume":"121","author":"YY Cho","year":"2015","unstructured":"Cho YY, Lim J, Oh CM, Ryu J, Jung KW, Chung JH et al (2015) Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea. Cancer 121(2):259\u2013268","journal-title":"Cancer"},{"issue":"10","key":"3793_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140693","volume":"10","author":"JY Joung","year":"2015","unstructured":"Joung JY, Lim J, Oh CM, Jung KW, Cho H, Kim SH et al (2015) Risk of second primary cancer among prostate cancer patients in Korea: a population-based cohort study. PLoS ONE 10(10):e0140693","journal-title":"PLoS ONE"},{"issue":"R1","key":"3793_CR23","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G (2014) Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 23(R1):R89-98","journal-title":"Hum Mol Genet"},{"issue":"9","key":"3793_CR24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1055-9965.EPI-17-1177","volume":"27","author":"J Yarmolinsky","year":"2018","unstructured":"Yarmolinsky J, Wade KH, Richmond RC, Langdon RJ, Bull CJ, Tilling KM et al (2018) Causal inference in cancer epidemiology: what is the role of Mendelian randomization? Cancer Epidemiol Biomark Prev 27(9):995\u20131010","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"3793_CR25","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/ije\/dyw088","volume":"45","author":"DI Swerdlow","year":"2016","unstructured":"Swerdlow DI, Kuchenbaecker KB, Shah S, Sofat R, Holmes MV, White J et al (2016) Selecting instruments for Mendelian randomization in the wake of genome-wide association studies. Int J Epidemiol 45(5):1600\u20131616","journal-title":"Int J Epidemiol"},{"issue":"11","key":"3793_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049361","volume":"7","author":"L Jin","year":"2012","unstructured":"Jin L, Xu L, Song X, Wei Q, Sturgis EM, Li G (2012) Genetic variation in MDM2 and p14ARF and susceptibility to salivary gland carcinoma. PLoS ONE 7(11):e49361","journal-title":"PLoS ONE"},{"issue":"6","key":"3793_CR27","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1086\/426403","volume":"75","author":"C Cybulski","year":"2004","unstructured":"Cybulski C, G\u00f3rski B, Huzarski T, Masoj\u0107 B, Mierzejewski M, Debniak T et al (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75(6):1131\u20131135","journal-title":"Am J Hum Genet"},{"issue":"3","key":"3793_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00259-020-05018-z","volume":"48","author":"P Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","unstructured":"Petranovi\u0107 Ov\u010dari\u010dek P, Verburg FA, Hoffmann M, Iakovou I, Mihailovic J, Vrachimis A et al (2021) Higher thyroid hormone levels and cancer. Eur J Nucl Med Mol Imaging 48(3):808\u2013821","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"3793_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.tem.2020.07.002","volume":"31","author":"AR Costa","year":"2020","unstructured":"Costa AR, Lan\u00e7a de Oliveira M, Cruz I, Gon\u00e7alves I, Cascalheira JF, Santos CRA (2020) The sex bias of cancer. Trends Endocrinol Metab 31(10):785\u2013799","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"3793_CR30","first-page":"39","volume":"4","author":"Y Imai","year":"1989","unstructured":"Imai Y, Yamakawa M, Matsuda M, Kasajima T (1989) Endogenous sex hormone and estrogen binding activity in thyroid cancer. Histol Histopathol 4(1):39\u201345","journal-title":"Histol Histopathol"},{"issue":"2","key":"3793_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a038984","volume":"11","author":"E Sanderson","year":"2021","unstructured":"Sanderson E (2021) Multivariable Mendelian randomization and mediation. Cold Spring Harbor Perspect Med 11(2):1","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"4","key":"3793_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/aje\/kwu283","volume":"181","author":"S Burgess","year":"2015","unstructured":"Burgess S, Thompson SG (2015) Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol 181(4):251\u2013260","journal-title":"Am J Epidemiol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03793-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03793-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03793-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T17:12:46Z","timestamp":1706116366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03793-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["3793"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03793-w","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2023,9,23]]},"assertion":[{"value":"30 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There were no conflicts of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The data is publicly available and ethics approval is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}